APLP2 was also reported to be highly expressed in pancreatic cancer cell lines, especially the APLP2 C-terminal fragment and the APLP2-modified glycosaminoglycan in relation to APP full-length and C-terminal fragments [122]. This evidence concerns the gene APLP2 and pancreatic neoplasm.